Moderna reports 'robust' Covid vaccine response in children aged 6-11

US pharmaceutical giant Moderna on Monday reported a "robust neutralizing antibody response" to its Covid vaccine in children aged 6-11, and said that it will submit the trial data to global regulators soon.